Original Research

Efficacy of trastuzumab beyond progression as second-line chemotherapy for HER2-positive advanced gastric cancer

Sato Y, Yamashita H, Yagi K, Aikou S, Nishida M, Takenaka Y, Nomura S, Seto Y

Gastrointestinal Cancer: Targets and Therapy 2017, 7:39-45

Published Date: 1 December 2017